Blood tests for tumor DNA (ctDNA) can spot leftover cancer months before scans do, and help doctors pick targeted drugs. New JAMA review: promising, but costs and best-use timing are still being worked out.
#LiquidBiopsy #ctDNA #CancerCare
jamanetwork.com/journals/jam...
jamanetwork.com
Liquid Biopsies for Cancer
This narrative review examines how liquid biopsy, particularly circulating tumor DNA, can guide treatment decisions by helping clinicians monitor cancer progression, detect minimal residual cancer, an...